Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02941666
Other study ID # 16-002241
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date September 2016
Est. completion date May 2022

Study information

Verified date December 2022
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Previous studies have shown an increase in the concentration of mesenchymal stem cells (MSC's) in the setting of osteoarthritis of the knee and its correlation to severity. Researchers have shown that as there is an increase in the severity of the disease, the concentration of stem cells also increases. The purpose of this study is to determine if there is the same increase in stem cell concentration in patients with osteonecrosis (ON) of the femoral head.


Description:

Since the treatment of osteonecrosis is related to the severity of disease, namely articular cartilage collapse, the purpose of this study is to determine if the MSC concentration in synovial fluid can be correlated to disease stage. In order to do this the investigators will: Milestone #1: Determine the concentration of MSC's in the synovial fluid in patients with osteonecrosis. This work will be carried out utilizing FACS-based technique to synovial fluid stem cell sub-population. Milestone #2: Compare concentrations of MSC's in patients with pre collapse, post collapse osteonecrosis and "normal" hips. Patient-derived MSC will be quantified at the different stages of disease and assays will be performed in order to assess their viability. A control group will be selected in patients undergoing hip arthroscopy for femoral/acetabular impingement (FAI). Since FAI does not affect the intraarticular environment of the hip, theoretically these patients would have a "normal" concentration of synovial stem cells.


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date May 2022
Est. primary completion date May 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Patients consented to undergo a THA (post-collapse osteonecrosis), hip arthroscopy or minimally invasive core decompression - Preoperative radiographic diagnosis of ON or FAI (femoral/acetabular impingement) Exclusion Criteria: - Pregnant females - Active infection, HIV, Hepatitis C or B, syphilis Immunodeficiency - Patients receiving hematopoetic growth factors or anti-angiogenesis products

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The quantity of mesenchymal stem cells present in the synovial fluid of patients with precollapse ON of the femoral head and postcollapse ON of the femoral head compared to patients without intraarticular hip pathology. Previous studies have shown an increase in the concentration of MSCs in the setting of osteoarthritis of the knee and its correlation to severity. Researchers have shown that as there is an increase in the severity of the disease, the concentration of stem cells also increases. The purpose of this study is to determine if there is the same increase in stem cell concentration in patients with osteonecrosis (ON) of the femoral head. Since the treatment of osteonecrosis is related to the severity of disease, namely articular cartilage collapse, the purpose of this study is to determine if the MSC concentration in synovial fluid can be correlated to disease stage. 24 months
See also
  Status Clinical Trial Phase
Terminated NCT04072055 - MOTO Post-marketing Surveillance Study
Terminated NCT01763684 - Oxford Signature vs. Conventional Global Study N/A
Completed NCT00505219 - Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head Phase 3
Withdrawn NCT02632903 - Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study Phase 2
Active, not recruiting NCT01458782 - ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee N/A
Completed NCT01583465 - Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty N/A
Active, not recruiting NCT04401267 - Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma Phase 2
Completed NCT03197623 - Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids Phase 1
Active, not recruiting NCT05283148 - Sickle Cell Disease (SCD) Bone Pain Study N/A
Completed NCT05684588 - Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head N/A
Terminated NCT03269409 - Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis Phase 1
Completed NCT00913679 - A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty N/A
Enrolling by invitation NCT02893293 - Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI Phase 4
Completed NCT01345097 - A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients Phase 4
Recruiting NCT00260897 - Molecular Genetic Study of Avascular Necrosis of the Femoral Head N/A
Not yet recruiting NCT06016634 - Alendronate for Osteonecrosis in Adults With Sickle Cell Disease Phase 2
Completed NCT02077647 - Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
Recruiting NCT01619124 - Osteonecroses in Pediatric Patients With ALL N/A
Completed NCT02458937 - Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
Recruiting NCT02661139 - Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction

External Links